Study and treatment of post Lyme disease (STOP-LD)
A trial on 55 PLS patients found IV ceftriaxone improved fatigue but not cognitive function or infection markers. Adverse events occurred, suggesting caution with additional antibiotic therapy for PLS fatigue.
Reference News
Study and treatment of post Lyme disease (STOP-LD)
A trial on 55 PLS patients found IV ceftriaxone improved fatigue but not cognitive function or infection markers. Adverse events occurred, suggesting caution with additional antibiotic therapy for PLS fatigue.